Umifenovir
Synonyms: arbidol
Tags:
drug
small molecule
DrugBank: DB13609 DB13609 Related interactions
Related publications
Title
Author
Type
Associations of clinical characteristics and antiviral drugs with viral RNA clearance in patients with COVID-19 in Guangzhou, China: a retrospective cohort study Xudan Chen, Yang Zhang, Baoyi Zhu, Jianwen Zeng, Wenxin Hong, Xi He, Jingfeng Chen, Haipeng Zheng, Shuang Qiu, Ying Deng, Juliana Chan, Jian Wang
Research
Molecular Investigation of SARS–CoV-2 Proteins and Their Interactions with Antiviral Drugs Calligari P, Bobone S, Ricci G, Bocedi A
Research
Treatments for COVID-19: emerging drugs against the coronavirus Francesco Potì, Cristina Pozzoli , Maristella Adami, Enzo Poli, Lucio G. Costa
Review
COVID-19: An Update about the Discovery Clinical Trial Jean Jacques Vanden Eynde
Comment
Accelerating drug development through repurposed FDA approved drugs for COVID-19: speed is important, not haste James T. Gordy, Kaushiki Mazumdar, Noton K. Dutta
Other
Review of trials currently testing treatment and prevention of COVID-19. P. C. Fragkou, D. Belhadi, N. Peiffer-Smadja, C. D. Moschopoulos, F. X. Lescure, H. Janocha, E. Karofylakis, Y. Yazdanpanah, F. Mentré, C. Skevaki, C. Laouénan, S. Tsiodras
Review
In vitro evaluation of antiviral activity of single and combined repurposable drugs against SARS-CoV-2 Andrés Pizzorno, Blandine Padey, Julia Dubois, Thomas Julien, Aurélien Traversier, Victoria Dulière, Pauline Bruna, Bruno Lina, Manuel Rosa-Calatrava, Olivier Terriera
Other
Target
Target affiliation
Drug
Type
Result
Target
Target affiliation
Drug
Type
Result
Name
Synonyms
Genes
Origin
Name
Synonyms
Genes
Origin
Name
Synonyms
PubChem
DrugBank
RCSB PDB
ATC
Name
Synonyms
PubChem
DrugBank
RCSB PDB
ATC
Title
Authors
DOI
Source
Article type
Date
Title
Authors
DOI
Source
Article type
Date
Title
Status
Phases
Start Date
Prim. Comp. Date
Comp. Date
First Post. Date
Title
Status
Phases
Start Date
Prim. Comp. Date
Comp. Date
First Post. Date
CORDITE (CORona Drug InTEractions database) collects and aggregates data from PubMed, MedRxiv, BioRxiv, ChemRxiv and PMC for SARS-CoV-2. Its main focus is set on drug interactions either addressing viral proteins or human proteins that could be used to treat COVID.
It collects and provides up-to-date information on computational predictions, in vitro, as well as in vivo study data.
The information provided is for research only and we cannot guarantee the correctness of the data.
Please contact dominik.heider@uni-muenster.de for further information.
Programmable access
There is an open API for access programmatically to the database. The API will print a JSON output:
Interactions
https://cordite-api.uni-muenster.de/api.php?action=list&table=interaction Targets
https://cordite-api.uni-muenster.de/api.php?action=list&table=target Drugs
https://cordite-api.uni-muenster.de/api.php?action=list&table=drug Publications
https://cordite-api.uni-muenster.de/api.php?action=list&table=publication Clinical trials
https://cordite-api.uni-muenster.de/api.php?action=list&table=clinical_trial
